Clinical Trials Browser

Phase 2 × Nasopharyngeal Carcinoma × tegafur-gimeracil-oteracil × Clear all

NCT03904225 2021-06-23

Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis

Phase 2 Unknown

Nasopharyngeal Carcinoma